Search PubMed⌕ Search
Home/Archive/PubMed

PubMed · 8970056

Methotrexate osteopathy, does it exist?

K Maenaut·R Westhovens·J Dequeker
View original source ↗Export metadata ↓

Abstract

We describe 2 postmenopausal women with rheumatoid arthritis (RA). They developed fractures during their treatment with weekly low dose methotrexate (MTX). The adverse effect of longterm low dose regimens of MTX on bone metabolism has been described as "methotrexate osteopathy," an analogy of the syndrome known in pediatric oncology. MTX may be an additional risk factor for osteoporosis and fractures in RA. This therapy should be relatively contraindicated in patients with multiple risk factors for osteoporosis.

Explore related subjects

Antirheumatic AgentsArthritis, RheumatoidBone DiseasesDose-Response Relationship, DrugFemaleFractures, StressHumansMethotrexateMiddle AgedPostmenopauseRadiographyRadionuclide ImagingTime FactorsCase ReportsJournal Article

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

K Maenaut, R Westhovens, J Dequeker. 1996. Methotrexate osteopathy, does it exist?. https://pubmed.ncbi.nlm.nih.gov/8970056/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2001

[New therapy approaches in rheumatoid arthritis. Preventing early joint destruction].

New perceptions about the cellular and molecular interactions involved in the inflammatory process have created a basis for specific treatment of rheumatoid arthritis. The therapeutic arsenal has now been expanded to include more selective inhibitors of cyclooxygenase, antibodies and antagonists of the cytokines, and an inhibitor of pyrimidine synthesis. Large clinical trials have demonstrated the efficacy of early immunomodulatory treatment aimed at preventing joint destruction, as well as the superiority of the combination therapy over monotherapy with a long-acting antirheumatic agent. To date, uniform criteria for the evaluation of the results of treatment are, however, lacking.

Antirheumatic Agents↗